Device tax repeal bill draws Democratic co-sponsor; Malaysia device regulation gears up;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Malaysia expects to have its Medical Devices Authority (MDA) regulatory agency ready to go by June. All medical devices in the country will have to be registered with the MDA starting in November. Story

> U.S. Rep. Bill Owens (D-NY) will sign on as a co-sponsor to legislation that would repeal the 2.3% medical device tax on revenue set to take effect in 2013. The tax is designed to help fund parts of the health reform law. Story

> Bioptigen has gained 510(k) clearance for a non-invasive eye imaging system, which uses optical coherence tomography to scan the eye without touching it, MedCity News reports. Story

> PneumRx, a device company focused on treating lung disease, has snatched domain names from Bronchus Technologies, as well as patents focused on emphysema/interventional pulmonology technology. Release

> AngioDynamics, a medical device and surgical tool maker, has named George Bourne as its new President and Chief Technology Officer. He's a veteran executive from companies including Boston Scientific, Navilyst Medical and Hologic. Release

> Israel's Ben-Gurion University is collaborating with the Cincinnati Children's Hospital Medical Center to address the lack of medical devices designed specifically for use in kids. Article

> A 15-year-old student from Maryland won top honors at Intel's International Science and Engineering with a sensor he invented to test blood or urine for early-stage pancreatic cancer. More

Biotech News

 @FierceBiotech: Celery extract shrinks difficult breast cancer tumor in mouse trials. Article | Follow @FierceBiotech

 @JohnCFierce: Scrap drug patents in favor of drug prizes? Vermont's Bernie Sanders draws up another fun bill with no hope of success. More | Follow @JohnCFierce

> iPierian salvages new game plan after stem cell tech loses its sizzle. Story

> AstraZeneca pulling out all stops in R&D deal frenzy. News

> User fee legislation promises better access, speedier reviews at FDA. More

> FDA staff backs J&J's Xarelto for heart condition. Article

Pharma News

 @FiercePharma: Potentially good for Hep C drugmakers: CDC calls for all boomers to get tested. Could ID 800K cases--Bloomberg. More | Follow @FiercePharma

> How does pharma's CEO pay rank? Article

> FDA review backs Xarelto for big new use in ACS patients. Story

> Pfizer recalled 653,000 bottles of smelly Advil. More

Biotech IT News

 @RyanMFierce: Click on #FBITchat & tune in for my chat with @Medidata's @CaptainClinical on innovations in clinical trials tomorrow. More | Follow @RyanMFierce

> Accelrys snaps up discovery software from Scynexis. More

> Ex-Apple CEO forecasts tech-driven change in medicine. News

> Startup Knode takes off with pharma fuel. Story

And Finally... Nearly one in four American teenagers may be close to developing Type 2 diabetes or could already be diabetic, a sharp increase compared to a decade ago, according to a new study featured in The New York Times's "Well" blog. Item

Suggested Articles

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.

CapsoVision has received word from the FDA that they may offer the home use of their ingestible camera pill for scanning the small intestine.